Extracorporeal membrane oxygenation (ECMO) for the treatment of cardiogenic shock : identification of pre-implant outcome predictors
Author: Fux, Thomas
Date: 2018-11-02
Location: Eugeniasalen, Eugeniahemmet T3:02, Karolinska University Hospital, Solna
Time: 09.00
Department: Inst för molekylär medicin och kirurgi / Dept of Molecular Medicine and Surgery
View/ Open:
Thesis (1.861Mb)
Abstract
Background: Refractory cardiogenic shock (RCS), cardiac arrest (CA) and postarrest cardiogenic shock (CS) are associated with high mortality. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used and can offer acute cardiopulmonary life support in this critically ill population but selection of VA-ECMO candidates remains challenging. There are limited data on which pre-VA-ECMO variables that predict outcome.
Aims: To identify pre-VA-ECMO predictors for 90-day mortality in Study I unselected, Study II postcardiotomy and Study III non-surgical patients with RCS, and Study IV in patients with CA or postarrest cardiogenic shock prior to VA-ECMO were studied.
Methods: Study I-IV were observational and retrospective. Study I included 181 mixed patients with RCS, Study II 105 patients with refractory postcardiotomy CS, Study III 76 non-surgical patients with RCS and Study IV 72 patients with CA or postarrest CS prior to VA-ECMO cannulation. The association between pre-implant variables and all-cause mortality at 90 days was analyzed with uni- and multivariable logistic regression.
Results: Study I. Main etiologies of RCS were post-cardiotomy failure 58%, acute myocardial infarction 22% and other medical etiologies 20%. Median duration of VA-ECMO support was 7 days (interquartile range [IQR]: 3-13). The 90-day overall mortality was 54%. Arterial lactate (odds ratio [OR] per unit: 1.14; 95% confidence interval [CI]: 1.06-1.23; p <0.001), number of inotropes and vasopressors (OR per agent: 1.58; 95% CI: 1.13-2.21; p = 0.008), and ischemic heart disease (IHD), (OR: 2.90; 95% CI: 1.31-6.39; p = 0.008) were independent predictors of 90-day mortality. Study II. Main surgical subgroups were single non-CABG 29%, isolated CABG 20%, 2 and 3 concomitant surgical procedures, 31% and 20%, respectively. Median duration of VA-ECMO was 7 days (IQR: 3-14). The 90-day overall mortality and in-hospital mortality was 57% and 56%, respectively. Arterial lactate (OR per unit: 1.22; 95% CI:1.07-1.40; p = 0.004), and IHD (OR: 7.87; 95% CI: 2.55-24.3; p <0.001) were independent predictors of 90-day mortality. Study III. Main etiologies of RCS were acute myocardial infarction 51% and acute heart failure of other etiologies 49%. Median duration of VA-ECMO was 5 days (IQR: 2-11). The 90-day overall mortality was 49% and in-hospital mortality was 50%. Arterial lactate (OR per mmol/L: 1.15; 95% CI: 1.06-1.24; p = 0.001) and number of inotropes and vasopressors (OR per agent: 2.14; 95% CI: 1.26-3.63; p = 0.005) were independent predictors of 90-day mortality. Study IV. Out-of-hospital CA occurred in 12% of the patients. Initial cardiac rhythm was non-shockable in 57%, and shockable in 43% of the patients. Median cardiopulmonary resuscitation duration was 21 minutes (IQR: 10-73, range:1-197). No return of spontaneous circulation (ROSC) was present in 64% and postarrest CS in 36% of the patients at VA-ECMO cannulation. Median duration of VA-ECMO was 5 days (IQR: 2-12). The 90-day overall mortality and in-hospital mortality were 57%, respectively, and 53% died during VA-ECMO. All survivors (43%) had cerebral performance category score 1-2 at discharge to home. Initial non-shockable CA rhythm (OR: 12.2; 95% CI 2.83-52.7; p = 0.001), arterial lactate (OR per unit: 1.15; 95% CI: 1.01-1.31; p = 0.041), and IHD (OR: 7.39; 95% CI: 1.57-34.7; p = 0.011) as independent predictors of 90-day mortality.
Conclusions: Identified independent pre-implant predictors for 90-day mortality after VA-ECMO initiation were in Study I arterial lactate, number of inotropes and vasopressors, and IHD, Study II arterial lactate and IHD, Study III arterial lactate, number of inotropes and vasopressors, Study IV initial non-shockable CA rhythm, arterial lactate and IHD. These predictors are easily available for pre-VA-ECMO risk prediction.
Aims: To identify pre-VA-ECMO predictors for 90-day mortality in Study I unselected, Study II postcardiotomy and Study III non-surgical patients with RCS, and Study IV in patients with CA or postarrest cardiogenic shock prior to VA-ECMO were studied.
Methods: Study I-IV were observational and retrospective. Study I included 181 mixed patients with RCS, Study II 105 patients with refractory postcardiotomy CS, Study III 76 non-surgical patients with RCS and Study IV 72 patients with CA or postarrest CS prior to VA-ECMO cannulation. The association between pre-implant variables and all-cause mortality at 90 days was analyzed with uni- and multivariable logistic regression.
Results: Study I. Main etiologies of RCS were post-cardiotomy failure 58%, acute myocardial infarction 22% and other medical etiologies 20%. Median duration of VA-ECMO support was 7 days (interquartile range [IQR]: 3-13). The 90-day overall mortality was 54%. Arterial lactate (odds ratio [OR] per unit: 1.14; 95% confidence interval [CI]: 1.06-1.23; p <0.001), number of inotropes and vasopressors (OR per agent: 1.58; 95% CI: 1.13-2.21; p = 0.008), and ischemic heart disease (IHD), (OR: 2.90; 95% CI: 1.31-6.39; p = 0.008) were independent predictors of 90-day mortality. Study II. Main surgical subgroups were single non-CABG 29%, isolated CABG 20%, 2 and 3 concomitant surgical procedures, 31% and 20%, respectively. Median duration of VA-ECMO was 7 days (IQR: 3-14). The 90-day overall mortality and in-hospital mortality was 57% and 56%, respectively. Arterial lactate (OR per unit: 1.22; 95% CI:1.07-1.40; p = 0.004), and IHD (OR: 7.87; 95% CI: 2.55-24.3; p <0.001) were independent predictors of 90-day mortality. Study III. Main etiologies of RCS were acute myocardial infarction 51% and acute heart failure of other etiologies 49%. Median duration of VA-ECMO was 5 days (IQR: 2-11). The 90-day overall mortality was 49% and in-hospital mortality was 50%. Arterial lactate (OR per mmol/L: 1.15; 95% CI: 1.06-1.24; p = 0.001) and number of inotropes and vasopressors (OR per agent: 2.14; 95% CI: 1.26-3.63; p = 0.005) were independent predictors of 90-day mortality. Study IV. Out-of-hospital CA occurred in 12% of the patients. Initial cardiac rhythm was non-shockable in 57%, and shockable in 43% of the patients. Median cardiopulmonary resuscitation duration was 21 minutes (IQR: 10-73, range:1-197). No return of spontaneous circulation (ROSC) was present in 64% and postarrest CS in 36% of the patients at VA-ECMO cannulation. Median duration of VA-ECMO was 5 days (IQR: 2-12). The 90-day overall mortality and in-hospital mortality were 57%, respectively, and 53% died during VA-ECMO. All survivors (43%) had cerebral performance category score 1-2 at discharge to home. Initial non-shockable CA rhythm (OR: 12.2; 95% CI 2.83-52.7; p = 0.001), arterial lactate (OR per unit: 1.15; 95% CI: 1.01-1.31; p = 0.041), and IHD (OR: 7.39; 95% CI: 1.57-34.7; p = 0.011) as independent predictors of 90-day mortality.
Conclusions: Identified independent pre-implant predictors for 90-day mortality after VA-ECMO initiation were in Study I arterial lactate, number of inotropes and vasopressors, and IHD, Study II arterial lactate and IHD, Study III arterial lactate, number of inotropes and vasopressors, Study IV initial non-shockable CA rhythm, arterial lactate and IHD. These predictors are easily available for pre-VA-ECMO risk prediction.
List of papers:
I. Fux T, Holm M, Corbascio M, van der Linden J, Lund LH. Pre-Implant Outcome Predictors in Patients with Refractory Cardiogenic Shock supported with VA-ECMO. J Am Coll Cardiol. 2017 Oct 17;70(16):2094-2096.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock: Risk Factors for Mortality. J Thorac Cardiovasc Surg. 2018. [Accepted]
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. VA-ECMO Support in Non-Surgical Patients with Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors. Artificial Organs. 2018. [Accepted]
Fulltext (DOI)
Pubmed
IV. Fux T, Holm M, Corbascio M, van der Linden J. Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation; Risk Factors for Mortality. [Submitted]
I. Fux T, Holm M, Corbascio M, van der Linden J, Lund LH. Pre-Implant Outcome Predictors in Patients with Refractory Cardiogenic Shock supported with VA-ECMO. J Am Coll Cardiol. 2017 Oct 17;70(16):2094-2096.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock: Risk Factors for Mortality. J Thorac Cardiovasc Surg. 2018. [Accepted]
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. VA-ECMO Support in Non-Surgical Patients with Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors. Artificial Organs. 2018. [Accepted]
Fulltext (DOI)
Pubmed
IV. Fux T, Holm M, Corbascio M, van der Linden J. Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation; Risk Factors for Mortality. [Submitted]
Institution: Karolinska Institutet
Supervisor: van der Linden, Jan
Co-supervisor: Lund, Lars H.; Corbascio, Matthias
Issue date: 2018-10-11
Rights:
Publication year: 2018
ISBN: 978-91-7831-190-3
Statistics
Total Visits
Views | |
---|---|
Extracorporeal ...(legacy) | 306 |
Extracorporeal ... | 267 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Extracorporeal ... | 3 | 3 | 0 | 3 | 1 | 2 | 1 |
File Visits
Views | |
---|---|
Thesis_Thomas_Fux.pdf | 388 |
Thesis_Thomas_Fux.pdf(legacy) | 151 |
null(legacy) | 1 |
Top country views
Views | |
---|---|
Sweden | 161 |
United States | 121 |
Germany | 38 |
China | 37 |
India | 13 |
Canada | 9 |
EU | 9 |
France | 9 |
Japan | 9 |
Belgium | 8 |
Top cities views
Views | |
---|---|
Ashburn | 60 |
Stockholm | 45 |
Huddinge | 14 |
Solna | 10 |
Boardman | 9 |
Guangzhou | 9 |
Dublin | 7 |
Uddevalla | 7 |
Pune | 6 |
Shanghai | 6 |